leisure time -WSS

leisure time

author：knowledge 2025-10-02 19:38:24 - browse：4

Eric Lander White House science office — Eric Lander resigned as President Biden’s science adviser, after a White House investigation found “credible evidence” that he had violated workplace conduct rules. Photo illustration: Alex Hogan/STAT; Source: Getty

WASHINGTON — An early sign that trouble was afoot in the White House science office came last November, when roughly a dozen of Eric Lander’s staff formed a “culture committee” aimed at improving morale.

The group’s first action, five aides told STAT, was to create a “word cloud” depicting the adjectives they most often used to describe the work environment at the White House Office of Science and Technology Policy. Of the dozens of words submitted, three in particular stood out: “hostile,” “siloed,” and “aggressive.”

Three months later, Lander resigned as President Biden’s science adviser, after Politico reported a White House investigation that found “credible evidence” that he had violated workplace conduct rules.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Latest bird flu infection made farmworker sicker than earlier cases

focus

hotspot

WSS

Latest bird flu infection made farmworker sicker than earlier cases

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

David Liu startup to focus on CRISPR delivery

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Startling documents reveal new facets of Sacklers' opioid empire

hotspot

leisure time

focus

In Memoriam: Notable people who died in 2023

Adam's Biotech Scorecard: Do Sarepta's exon

In age of alternative facts, a scholarly course on calling out crap

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

United colonoscopy coverage change 'may cost lives,' doctors say

Prosthetic arm enables patients to feel the objects they grip

Novavax promises a turnaround & Lilly roils the obesity market

Neurocrine congenital adrenal hyperplasia trial succeeds

How to save PrEP access — and even expand it

iTeos Therapeutics debuts first data on TIGIT

hotspot

Addiction doctors spar with methadone clinics over legislation

Fed up with FDA, ALS advocates consider a take

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

The struggle to figure out which patients 'deserve' Wegovy

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

David Sabatini, ex

hotspot

focus

hotspot

hotspot